Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.66%571.58M | -27.21%1.26B | -24.99%632.71M | 8.95%1.73B | -1.82%843.54M | -13.02%1.59B | 0.79%859.2M | 15.92%1.83B | 11.47%852.48M | 7.44%1.57B |
| Operating income | -9.66%571.58M | -27.21%1.26B | -24.99%632.71M | 8.95%1.73B | -1.82%843.54M | -13.02%1.59B | 0.79%859.2M | 15.92%1.83B | 11.47%852.48M | 7.44%1.57B |
| Cost of sales | 13.12%-445.01M | 25.54%-1.01B | 26.74%-512.19M | -4.32%-1.35B | 1.25%-699.12M | 14.66%-1.3B | 2.29%-707.96M | -20.24%-1.52B | -13.92%-724.58M | -10.10%-1.27B |
| Operating expenses | 13.12%-445.01M | 25.54%-1.01B | 26.74%-512.19M | -4.32%-1.35B | 1.25%-699.12M | 14.66%-1.3B | 2.29%-707.96M | -20.24%-1.52B | -13.92%-724.58M | -10.10%-1.27B |
| Gross profit | 5.03%126.57M | -33.27%249.94M | -16.56%120.51M | 29.81%374.56M | -4.51%144.43M | -4.79%288.54M | 18.25%151.24M | -1.80%303.04M | -0.63%127.9M | -2.28%308.6M |
| Selling expenses | -19.97%-45.87M | 1.26%-89.39M | 2.09%-38.23M | -8.68%-90.53M | 20.51%-39.05M | 4.91%-83.29M | -65.36%-49.13M | -9.31%-87.59M | 29.78%-29.71M | 26.41%-80.13M |
| Administrative expenses | -11.20%-27.39M | 1.73%-61.67M | -5.41%-24.63M | -30.96%-62.76M | -42.93%-23.37M | 9.23%-47.92M | 20.63%-16.35M | -3.99%-52.79M | 20.32%-20.6M | -7.58%-50.76M |
| Research and development expenses | 49.43%-18.84M | -42.85%-51.4M | -223.35%-37.25M | -30.49%-35.98M | 14.99%-11.52M | 9.65%-27.57M | -1.96%-13.55M | 11.46%-30.52M | -28.42%-13.29M | 26.03%-34.47M |
| Impairment and provision | -269.20%-1.65M | 104.31%1.86M | 134.02%974K | -269.20%-43.16M | 83.84%-2.86M | -49.28%-11.69M | -236.47%-17.72M | 66.94%-7.83M | 55.11%-5.27M | -163.49%-23.69M |
| -Other impairment is provision | -269.20%-1.65M | 104.31%1.86M | 134.02%974K | -269.20%-43.16M | 83.84%-2.86M | -49.28%-11.69M | -236.47%-17.72M | 66.94%-7.83M | 55.11%-5.27M | -163.49%-23.69M |
| Special items of operating profit | -9.00%15.59M | -6.78%37.11M | 60.60%17.13M | 49.16%39.81M | -34.19%10.67M | 375.45%26.69M | 304.85%16.21M | -84.66%5.61M | -78.21%4M | 678.65%36.59M |
| Operating profit | 25.75%48.42M | -52.48%86.46M | -50.82%38.5M | 25.69%181.94M | 10.73%78.3M | 11.41%144.75M | 12.16%70.71M | -16.78%129.93M | 10.90%63.04M | 59.64%156.13M |
| Financing cost | 97.31%-8K | 17.33%-501K | 1.33%-297K | -436.28%-606K | -14,950.00%-301K | -2,725.00%-113K | 0.00%-2K | 0.00%-4K | 0.00%-2K | 99.32%-4K |
| Earning before tax | 26.71%48.41M | -52.60%85.96M | -51.01%38.21M | 25.37%181.33M | 10.31%77.99M | 11.32%144.64M | 12.16%70.7M | -16.78%129.92M | 10.90%63.04M | 60.60%156.13M |
| Tax | -12.12%-6.41M | 59.75%-15.23M | 59.45%-5.72M | -67.57%-37.83M | -39.56%-14.11M | -15.07%-22.58M | -10.04%-10.11M | 18.63%-19.62M | -3.71%-9.19M | -39.30%-24.11M |
| After-tax profit from continuing operations | 29.28%42M | -50.71%70.74M | -49.15%32.49M | 17.57%143.5M | 5.43%63.89M | 10.66%122.06M | 12.52%60.6M | -16.44%110.31M | 12.22%53.85M | 65.21%132.01M |
| Earning after tax | 29.28%42M | -50.71%70.74M | -49.15%32.49M | 17.57%143.5M | 5.43%63.89M | 10.66%122.06M | 12.52%60.6M | -16.44%110.31M | 12.22%53.85M | 65.21%132.01M |
| Minority profit | -99.41%7K | 442.54%3.46M | 3,693.94%1.19M | 498.13%637K | 82.35%-33K | -114.93%-160K | 45.95%-187K | 1,292.21%1.07M | 56.09%-346K | -92.06%77K |
| Profit attributable to shareholders | 34.15%41.99M | -52.91%67.28M | -51.03%31.3M | 16.89%142.87M | 5.16%63.92M | 11.89%122.22M | 12.15%60.78M | -17.21%109.23M | 11.12%54.2M | 67.15%131.94M |
| Basic earnings per share | 34.19%0.084 | -52.89%0.1346 | -51.02%0.0626 | 16.90%0.2857 | 5.10%0.1278 | 11.85%0.2444 | 12.18%0.1216 | -17.20%0.2185 | 11.07%0.1084 | 30.77%0.2639 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.